title: Global Advisory Committee on Vaccine Safety, 11-12 June 2014.
mesh_terms: D026683:Advisory Committees / Q000458:organization & administration*; D005260:Female; D016751:Hepatitis E / Q000517:prevention & control; D016752:Hepatitis E virus / Q000276:immunology*; D006801:Humans; D008004:Licensure; D008288:Malaria / Q000517:prevention & control; D017780:Malaria Vaccines / Q000009:adverse effects*; D008589:Meningococcal Infections / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000009:adverse effects* / Q000276:immunology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000009:adverse effects* / Q000276:immunology; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology; D014761:Viral Hepatitis Vaccines / Q000009:adverse effects* / Q000276:immunology; D014944:World Health Organization
chemical_list: D017780:Malaria Vaccines; D022401:Meningococcal Vaccines; D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines